Background
==========

Liver transplantation success depends mainly on the liver graft. Without a suitable graft for the recipient, liver transplantation is impossible to perform. The small cadaveric donor pool is still a major problem, so living related liver transplantation is performed nearly 2 to 3 times more often than cadaveric liver transplantation in Turkey \[[@b1-medscimonit-23-5986]\]. The safety of living liver donors is the paramount priority of liver transplantation surgeons. In contrast of other organs, the liver has a very effective regeneration capacity \[[@b2-medscimonit-23-5986]\]. This allows transplant surgeons to take a part of the liver of a healthy person and transplant it to the recipient, who otherwise will not be able to survive. However, living liver donor hepatectomy is still a challenging operation that needs meticulous preoperative evaluation and selection of a liver donor, as well as excellent surgical skills, which directly affects the donor and the recipient. The regeneration rate of the liver remnant in living liver donors provides much information useful in successful liver surgery. The outcome of the remnant liver after hepatectomy for liver donation can be affected by many different perioperative factors. The present study aimed to determine the major factors affecting the hepatic regeneration rate after liver donor surgery in our series, with the goal of improving the overall safety of living liver donors.

Material and Methods
====================

From January 2012 to July 2017, 78 patients underwent hepatectomy as living liver donors in the Hepatopancreatobiliary (HPB) Surgery and Liver Transplantation Unit of the Istanbul Faculty of Medicine, Istanbul University. The medical records of the 78 patients were reviewed retrospectively. We excluded 32 patients because of missing data such as late postoperative abdominal computed tomography (CT) or magnetic resonance (MR) scans. Thus, a total of 46 patients were selected. Donors with suitable liver volume (resection rate ≤75%) were selected from among healthy relatives of recipients. All preoperative biochemical and laboratory values, as well as blood counts, had to be within normal limits. Viral serology also had to be negative. No systemic illnesses of donor candidates were allowed for liver donation. Normal liver biopsy results (without intermediate or high grades of steatosis) and BMI lower than 30 kg/m^2^ were also criteria for donor selection. Donor operations were all performed by the same surgical team using an ultrasonic surgical dissector-aspirator system during liver transection without using inflow occlusion (Pringle's) maneuver. According to our routine protocol, we performed postoperative 1^st^ day Doppler evaluation of remnant liver vasculature and postoperative 7^th^ day and postoperative late (\>30 days) tri-phasic abdominal CT imaging in all liver donors.

From the medical records, we collected the following data on the clinical profile of the patients: age, sex, height, weight, hepatectomy type, intraoperative hemoglobin (Hb) decrease (as an indicator of surgical bleeding), preoperative CT-determined total liver volume (preCT-TLV), preoperative CT-determined resected liver volume (preCT-resV), resected liver weight or volume (specific gravity of normal liver tissue is about 1.0 g/cm^3^, so the volume is taken as similar to the weight), calculated postoperative remnant liver volume (RLV) and percentage (RLV%), postoperative 7^th^ day CT-determined total liver volume (p7-CT-TLV), late postoperative CT-determined total liver volume (lateCT-TLV), and postoperative 1^st^ day portal flow rate according to Doppler measurement. We also recorded the following early and late postoperative (1^st^ and 7^th^ day) laboratory values: platelet (PLT) count, lactate dehydrogenase (LDH), creatinine (CREA), alanine aminotransaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT), total bilirubin (TBIL), international normalized ratio (INR), C-reactive protein (CRP), length of postoperative hospitalization, and postoperative complications days). From data in the patient record, were calculated the following: body mass index (BMI), body surface area (BSA) according to DuBois formula, total liver volume (TLV) according to the formula of Vauthey et al., postoperative 7^th^ day liver enlargement rate (between post-hepatectomy and postoperative 7^th^ day abdominal imaging) (P7LER), postoperative total liver enlargement rate (between post-hepatectomy and last postoperative abdominal imaging) (PTLER), postoperative 7-day liver enlargement in ml (P7ml), postoperative 7-day liver enlargement in ml/day (P7ml/day), and postoperative total liver enlargement in ml/day (PTLEml/day). We have calculated: RLV=preCT-TLV--preCT-resV, P7LER=\[(p7-CT-TLV--RLV)/RLV\]×100, PTLER=\[(lateCT-TLV--RLV)/RLV\]×100, P7ml=(p7-CT-TLV--RLV), P7ml/day=(p7-CT-TLV--RLV)/7, and the PTLEml/day=(lateCT-TLV--RLV)/n {where n is used to infer total number of postoperative days till the last abdominal imaging}.

We decided to use the preCT-resV rather than the resected liver weight in calculation of enlargement rates because we believe that CT-gained valuables should not be mixed with the weight-measurements after hepatectomy in order to estimate the liver enlargement rates \[[@b4-medscimonit-23-5986]--[@b6-medscimonit-23-5986]\]. We used CT-MR volumetry software (ExtemePACS 2016 Ankara, Turkey, licensed to Istanbul University) for liver volume determination. All postoperative morbidities were recorded and graded according to the Clavien-Dindo classification. Postoperative liver failure was defined according to the International Study Group of Liver Surgery (ISGLS) grading. The study protocol was approved by the Ethics Committee of Istanbul University Istanbul Medical Faculty (2017/1132).

Statistical evaluation
----------------------

Data analysis was performed with SPSS 21.0 statistics software (SPSS Inc., Chicago, IL, USA, Licensed to Istanbul University). Mean P7LER, PTLER, P7ml, P7ml/day, PTLEml/day, median days of hospitalization, standard deviations, and frequencies were calculated. The differences between groups were analyzed with the *t* test for categorical variables and the Mann-Whitney U test for continuous variables. We used the Kruskal-Wallis test and Spearman's or Pearson's correlation analysis to compare the liver enlargement rates, type of hepatectomy, length of hospitalization, complication rate, biliary leakage rate, and Doppler-measured portal vein flow rate after hepatectomy. The correlation between TLV and preCT-TLV and between preCT-resV and resected liver weight was evaluated through calculation of intraclass correlation coefficient (ICC). An overall 5% Type-I error level was used to infer statistical significance with a confidence interval of 95%.

Results
=======

A total of 46 patients (17 \[37%\] females and 29 \[63%\] males) were included into our study. The median age was 31 years (range, 18 to 58). The median BMI was 24 kg/m^2^ (range, 18 to 29). After excluding some donors because they were outside the parameters of our study design, only 46 patients remained, who underwent right hepatectomy or left lateral sectionectomy for liver donation. Therefore, we established right hemihepatectomy (RHH) and left lateral sectionectomy (LLS) donor groups. The RHH group consisted of 21 (46%) patients and the LLS group consisted of 25 (54%) patients. Detailed characteristics of donors are given in [Table 1](#t1-medscimonit-23-5986){ref-type="table"}. The preoperative total blood count levels and biochemical values were all within normal limits in all of the liver donors. There were no statistically significant differences in sex, age, BMI, height, weight, TLV, preCT-TLV, postoperative portal flow rate, morbidities, biliary leakage rate, length of hospitalization, or intraoperative Hb decrease between the RHH and LLS groups (p\<0.05). TBIL1 (p=0.000), CRP1 (0.005), INR1 (p=0.000), ALT7 (p=0.045), TBIL7 (p=0.000), CRP7 (p=0.050), INR7 (p=0.000), PLT7 (p=0.001), and Prio values (p=0.0004) were found to be significantly different between RHH and LLS groups. Because we decided to use the preCT-TLV and preCT-resV rather than calculated-TLV according to the Vauthey et al. formula, and the resected liver weight after hepatectomy in order to calculate the postoperative liver enlargement rates, we compared them using ICC values for reliability. ICC values revealed that using preCT-resV and preCT-TLV is a reliable option {\[preCT-TLV and calculated-TLV: Cronbach's Alpha =0.778; Single Measures ICC=0.636; Average Measures ICC=0.778\] and \[preCT-resV and resected liver weight: Cronbach's Alpha=0.965; Single Measures ICC=0.933; Average Measures ICC=0.965\]}.

PTLER, PTLEml/day, P7LER, P7ml, and P7ml/day values are significantly higher in the RHH group than in the LLS group ([Table 2](#t2-medscimonit-23-5986){ref-type="table"}).

No statistically significant difference was found between males and females in terms of PTLER, PTLEml/day, P7LER, P7ml, and P7ml/day values.

No post-hepatectomy liver failure (PHLF) was detected among liver donors according to ISGLS criteria in RHH and LLS groups after liver resection for living related liver transplantation.

According to Clavien-Dindo classification, a total of 17 patients (37%) developed postoperative complications, including bile leakage, wound complications, controlled low-grade ascites, hemorrhage, subileus, or drug allergy (16 \[35%\] patients grade I, and 1 \[2%\] patient grade II) ([Table 3](#t3-medscimonit-23-5986){ref-type="table"}). There was no mortality (no mortality was also observed in our donor hepatectomy series since the beginning of our living-donor liver transplant program).

There was no statistically significant difference between donors with and without postoperative complications in terms of PTLER, PTLEml/day, P7LER, P7ml, and P7ml/day values (p=0.724, p=0.290, p=0.300, p=0.802, and p=0.392, respectively). Postoperative biliary leakage did not have any statistically significant effect on liver regeneration rates after hepatectomy (PTLER, PTLEml/day, P7LER, P7ml, and P7ml/day, p=0.879, p=0.552, p=0.648, p=0.740, and p=0740, respectively).

Spearman analysis showed a significant inverse relationship between PTLER and RLV% (p=0.000, r=−0.836), RLV (p=0.000, r=−0.820), p7-CT-TLV (p=0.000, r=−0.676), lateCT-TLV (p=0.003, r=−0.423), postoperative 1^st^ day CRP (CRP1) (p=0.027, r=−0.326), postoperative 1^st^ day PLT (p=0.022, r=−0.337), postoperative 7^th^ day ALT (p=0.050, r=−0.291), and postoperative 7^th^ day PLT (PLT2) (p=0.000, r=−0.523), and showed a positive relationship between PTLER and preCT-resV (p=0.000, r=0.756), resected liver weight (p=0.000, r=0.677), postoperative 1^st^ day TBIL (TBIL1) (p=0.001, r=0.486), postoperative 1^st^ day INR (INR1) (p=0.000, r=0.697), postoperative 7^th^ day TBIL (TBIL7) (p=0.000, r=0.658), and postoperative 7^th^ day INR (INR2) (p=0.000, r=0.581).

There was also a significant inverse relationship between P7LER and RLV%, preCT-TLV, RLV, p7-CT-TLV, lateCT-TLV, CRP1, and PLT7, and a positive relationship between P7LER and preCT-resV, resected liver weight, TBIL1, INR1, TBIL7, and INR7, according to Spearman analysis.

A negative correlation was found between P7ml and RLV%, RLV, CRP1, INR1, and preCT-TLV, PLT7, and a positive correlation was found between P7ml and preCT-resV, resected liver weight, and TBIL7.

P7ml/day values were inversely correlated with RLV%, CRP1, preCT-TLV, and PLT2, and were positively correlated with RLV, preCT-resV, resected liver weight, INR1, and TBIL7.

PTLEml/day values were positively correlated with preCT-resV, resected liver weight, TBIL1, INR1, TBIL7, and INR7, and were negatively correlated with RLV%, RLV, p7-CT-TLV, and PLT7.

No correlation was found between intraoperative Hb decrease and liver enlargement rates.

We created a new and simple parameter, called the "postoperative regeneration-inflammatory ratio" (PRIO), through dividing the PLT1 value by the CRP1 value to help predict the general trend of liver regeneration after hepatectomy ([Table 4](#t4-medscimonit-23-5986){ref-type="table"}). PRIO value was found to be positively but weakly correlated with PTLER (p=0.047, r=0.297) and P7LER (p=0.002, r=0.452).

Discussion
==========

The first successful liver transplantation was performed by Thomas Starzl in 1967 in the United States. The first liver transplant in Turkey was performed by Haberal in 1988. The first successful living donor liver transplant in Turkey was performed in 1990 by the same team \[[@b1-medscimonit-23-5986]\]. Turkey has one of the highest volumes of liver transplantation per population worldwide \[[@b1-medscimonit-23-5986]\]. This would be impossible in Turkey without living donor procedures because of the very limited number of cadaveric liver grafts due to several reasons. With the rising number of living donor liver transplantations, the safety of liver donors became a high priority in our department. Detailed preoperative evaluation and meticulous selection of donors is a *sine qua non* for living donor liver transplantation. The regeneration capacity of the liver enables successful transplantation of a partial liver graft \[[@b2-medscimonit-23-5986]\]. Several molecular pathways were described and reported in detail which expanded the knowledge of liver transplant surgeons as well as HPB surgeons about clinical aspects of liver regeneration \[[@b2-medscimonit-23-5986],[@b7-medscimonit-23-5986],[@b8-medscimonit-23-5986]\].

The statistical evaluation of our 2 groups (RHH and LLS) revealed that they are comparable---no significant difference was detected among age, sex, BMI, TLV, preCT-TLV, intraoperative Hb decrease, postoperative complications, or postoperative portal vein flow rate ([Tables 1](#t1-medscimonit-23-5986){ref-type="table"}, [3](#t3-medscimonit-23-5986){ref-type="table"}).

TBIL1, INR1, TBIL7, INR7, and PRIO levels were significantly higher in the RHH group than in the LLS group, and CRP1, CRP7, PLT7, and ALT7 values were found to be significantly higher in the LLS group than in the RHH group. After the LLS procedure, we detected significantly higher levels of CRP in donors than in RHH. PRIO values were significantly higher in the RHH group. After RHH, liver regeneration was significantly faster than in the LLS group. In the first postoperative week, there is a burst of growth in the remnant liver tissue. Mean values reached 60 ml/day and 35 ml/day in the first postoperative week in the RHH and LLS group, respectively. Mean P7LER values are also impressive in both groups: 94% (RHH) *vs.* 22% (LLS) ([Table 2](#t2-medscimonit-23-5986){ref-type="table"}). Several factors may affect regeneration rates. Spearman analysis showed that P7LER and PTLER have a strong negative correlation with RLV% and have a strong correlation with preCT-resV ([Figure 1](#f1-medscimonit-23-5986){ref-type="fig"}). Our results show that the size of the liver remnant or graft had the greatest impact on regeneration rate and had quantity similar to that previously reported \[[@b2-medscimonit-23-5986],[@b9-medscimonit-23-5986]--[@b11-medscimonit-23-5986]\]. BMI levels below 30 kg/m^2^ did not affect the regeneration rates after hepatectomy, consistent with Lock et al. \[[@b12-medscimonit-23-5986]\]. Although Margonis et al. reported a positive impact of early postoperative platelet count on volumetric liver enlargement, we were unable to show any significant difference between donors with PLT1 lower than 150×10^3^/mm^3^ and normal PLT1 values \[[@b13-medscimonit-23-5986]\]. Interestingly, we realized after comparison of the PLT7 values with the post-hepatectomy liver regeneration rates (cut-off level taken as 150×10^3^/mm^3^) that there was a statistically significant inverse correlation between PLT7 values and P7LER (p=0.039), p7ml (p=0.042), and P7ml/day (p=0.041). No significant correlation was detected between PLT7 and PTLER and PTLEml/day. Following RHH, with obviously greater resection volume, postoperative TBIL1, INR1, TBIL7, and INR2 values are higher than post-hepatectomy values after LLS. Liver regeneration after RHH is without doubt faster than after LLS in total as well as in the first week. Remarkable significant higher levels of CRP1, and CRP2 after LLS than RHH revealed that LLS provokes more inflammation than does RHH. The evaluation of our series in terms of postoperative CRP levels showed a moderate to weak negative correlation with the liver regeneration rates, similar to some previous reports \[[@b14-medscimonit-23-5986],[@b15-medscimonit-23-5986]\].

CT volumetry and TLV are reliable and non-invasive methods to determine the liver volume according to ICC evaluation. CT volumetry is more accurate in left lateral section grafts ([Figures 2](#f2-medscimonit-23-5986){ref-type="fig"}, [3](#f3-medscimonit-23-5986){ref-type="fig"}). RHH and LLS are different surgical resections. Both the amount of resected liver volume and the anatomic location of resected liver segments affect the postoperative regeneration process. Olthoff et al. studied a large series including living--liver donors (right and left hemilivers) and recipients \[[@b16-medscimonit-23-5986]\]. The liver regeneration rates of right or left liver remnants seem to be similar in their study. The features of enlargement rate of remnant liver after left lateral resection differs from the regeneration of remnant liver after hepatic lobectomies. After removal of left lateral section liver grafts, we observed that 7 out of 25 left lateral section donors (28%) had a low-grade shrinkage of the liver remnant (with negative PTLER values). Atrophy of the remnant liver can have several causes \[[@b2-medscimonit-23-5986]\]. The cause of volume decrease in the LLS group after hepatectomy in our series seems to be gradual atrophy of liver segment 4. The subgroup analysis of donors with negative PTLER showed no significant difference in terms of TBIL1, CRP1, PLT1, portal vein flow rate, or postoperative complications. Biliary leakage after hepatectomy was reported to be the cause of decreased regeneration rates in some studies \[[@b17-medscimonit-23-5986]\]. We showed that adequately drained biliary leaks did not deteriorate post-hepatectomy liver regeneration rates in our study. Various experimental studies were published related to acceleration of liver regeneration in the post-hepatectomy period \[[@b18-medscimonit-23-5986]--[@b20-medscimonit-23-5986]\]. Recently, associating liver partition and portal vein ligation for staged hepatectomy (ALPPS procedure) has become popular as a serious alternative to portal vein ligation and two-stage hepatectomy, but, according to the multicenter trial of Croome et al. \[[@b21-medscimonit-23-5986]\], the hypertrophy after ALPPS is not unique. We developed a simple "PRIO" index to predict the regeneration rate after hepatectomy. PRIO values were significantly higher in the RHH group. PRIO value was only weakly correlated with PTLER and P7LER, but we think that it is promising and deserves further study.

Conclusions
===========

Living-donor liver transplantation requires a healthy donor with a liver suitable for the recipient. Liver regeneration is a critical feature of this sophisticated organ which makes the transplant possible. The regeneration process begins on a molecular basis just after hepatectomy and has an obvious clinical impact on surgical outcome. In our small series, we were able to show results similar to those of several previous reports that liver hypertrophy depends on the extent of liver resection. Postoperative early PLT count was not found to be correlated with the regeneration rates in healthy liver donors. RHH and LLS surgeries differ from each other in terms of resected liver volume, as well as inflammatory activity during liver regeneration. No negative effect of postoperative biliary leakage on regeneration rates was found. Our new inflammatory quotient PRIO was found to be promising for the prediction of regeneration rates after hepatectomy. Living-donor liver transplantation can be performed safely with the help of strict donor selection criteria. Transplant surgeons should make every effort to select the best liver donor, perform the correct surgery in an excellent way, and support the metabolic environment of the remnant liver for optimum regeneration.
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![Total and 7^th^ day regeneration rates after right hemihepatectomy and left lateral sectionectomy. RHH -- right hemihepatectomy; LLS -- left lateral sectionectomy; PTLER -- postoperative total liver enlargement rate, P7LER -- postoperative 7^th^ day liver enlargement rate.](medscimonit-23-5986-g001){#f1-medscimonit-23-5986}

![Estimated resection volumes and actual resection weights of right hemiliver donors. preCT-resV -- preoperative estimated liver volume found by computed tomography volumetry, RHH -- right hemihepatectomy; resection weight -- resection volume in ml.](medscimonit-23-5986-g002){#f2-medscimonit-23-5986}

![Estimated resection volumes and actual resection weights of left lateral section donors. preCT-resV -- preoperative estimated liver volume found by computed tomography volumetry, LLS -- left lateral sectionectomy; resection weight -- resection volume in ml.](medscimonit-23-5986-g003){#f3-medscimonit-23-5986}

###### 

Characteristics of donors.

                                       Right hemihepatectomy   Left lateral sectionectomy   
  ------------------------------------ ----------------------- ---------------------------- ----------------
  Age                                  33.67 (±11.425)         31.72 (±7.850)               p=0.513
  Sex (male: female)                   13:8                    17:8                         n.s.
  BMI kg/m^2^                          23.38 (±2.729)          24.40 (±2.799)               p=0.219
  TLV ml                               1422 (±221)             1511 (±244)                  p=0.202
  Preop Ct Volumetry ml                1369 (±234)             1505 (±226)                  p=0.052
  Remnant Liver Volume %               35 (27--50)             81 (63--88)                  Median (range)
  Preop est. Ct Res. V ml              885 (515--1189)         284 (151--557)               Median (range)
  Resected liver weight g              770 (428--1110)         274 (146--470)               Median (range)
  Postop0 liver V ml                   484 (302--790)          1222 (948--1764)             Median (range)
  Postop7 liver V ml                   900 (683--1193)         1470 (1047--1846)            Median(range)
  PostopLate liver V ml                1004 (754--1277)        1363 (957--2029)             Median (range)
  Postop1 LDH IU/l                     398 (±145)              469 (±262)                   p=0.255
  Postop1 CREA mg/dl                   0.67 (±0.17)            0.65 (±0.14)                 p=0.627
  Postop1 TBIL mg/dl                   2.02 (±0.62)            1.14 (±0.61)                 p=0.000
  Postop1 ALP IU/l                     61 (±18)                58 (±25)                     p=0.622
  Postop1 AST IU/l                     195 (±124)              219 (±160)                   p=0.577
  Postop1 ALT IU/l                     229 (±178)              313 (±245)                   p=0.184
  Postop1 GGT U/l                      30 (±27)                25 (±18)                     p=0.461
  Postop1 INR                          1.4 (±0.16)             1.17 (±0.07)                 p=0.000
  Postop1 CRP mg/dl                    25 (±14)                43 (±25)                     p=0.007
  Postop1 PLT ×10^3^/mm^3^             206 (±42)               211 (±46)                    p=0.655
  Postop1 PVFlow cm/sec                39.3 (±14.6)            37.7 (±13.9)                 p=0.697
  Hb decrease g/dl                     0.7 (±0.6)              0.7 (±0.6)                   p=0.764
  Postop7 LDH IU/l                     308 (±164)              269 (±93)                    p=0.339
  Postop7 CREA mg/dl                   0.60 (±0.12)            0.7 (±0.15)                  p=0.476
  Postop7 TBIL mg/dl                   0.78 (±0.46)            0.27 (±0.12)                 p=0.000
  Postop7 ALP IU/l                     89 (±38)                100 (±60)                    p=0.461
  Postop7 AST IU/l                     58 (±28)                47 (±32)                     p=0.240
  Postop7 ALT IU/l                     89 (±31)                115 (±53)                    p=0.045
  Postop7 GGT U/l                      124 (±118)              81 (±49)                     p=0.127
  Postop7 INR                          1.2 (±0.16)             1 (±0.80)                    p=0.000
  Postop7 CRP mg/dl                    27.78 (±27.00)          45.92 (±33.99)               p=0.050
  Postop7 PLT ×10^3^/mm^3^ mean (SD)   195 (±61)               260 (±58)                    p=0.001

n.s. -- not significant; BMI -- body mass index; BSA -- body surface area; TLV -- total liver volume; Preop -- preoperative; Ct -- computed tomography; n.c. -- not suitable to compare; est. -- estimated; V -- volume; Postop0 liver V -- Liver volume just after resection; Postop7 liver V -- 7^th^ day postoperative liver volume; PostopLate liver V -- Liver volume calculation with a late postoperative Ct-scanning; Postop1 -- 1^th^ postoperative day; LDH -- lactate dehydrogenase; CREA -- creatinine; ALT -- alanin aminotransaminase; AST -- aspartate aminotrasnferase; ALP -- alkaline phosphatase; GGT -- gamma-glutamyltransferase; TBIL -- total bilirubin; INR -- international normalized ratio; CRP -- C-reactive protein; PLT -- platelet count; PVF -- portal vein flow; Hb -- hemoglobin; Postop7 -- 7^th^ postoperative day; SD -- standart deviation.

###### 

Liver enlargement rates and gained volumes.

                            RHH             LLS           
  ------------------------- --------------- ------------- ---------
  PTLER % median (range)    109 (21--198)   7 (−11--53)   p=0.000
  PTLEml/daymedian(range)   14 (4--22)      1 (−4--22)    p=0.000
  P7LER % mean (SD)         94 (±39)        22 (±16)      p=0.000
  P7ml mean (SD)            416 (±121)      246 (±170)    p=0.000
  P7ml/day mean (SD)        60 (±17)        35 (±24)      p=0.000

RHH -- right hemihepatectomy; LLS -- left lateral sectionectomy; PTLER -- postoperative total liver enlargement rate; PTLEml/day -- postoperative total liver enlargement in ml/day; P7LER -- postoperative 7^th^ day liver enlargement rate; SD -- standart deviation; P7ml -- postoperative 7 days liver enlargement in ml; P7ml/day -- postoperative 7 days liver enlargement in ml/day.

###### 

Morbidities after liver resection.

                                        RHH     LLS                 
  ------------------------------------- ------- ------------------- ---------
  Number of patients with morbidities   8       9                   p=0.905
  Clavien-Dindo (n; grade)              8;G I   8; G I and 1;G II   p=0.905
  Biliary leakage n                     4       5                   p=0.937
  PHLF n                                0       0                   

RHH -- right hemihepatectomy; LLS -- left lateral sectionectomy; n -- number of patients; G -- grade; PHLF -- posthepatectomy liver failure.

###### 

Postoperative regeneration-inflammatory ratio values.

                            RHH             LLS            
  ------------------------- --------------- -------------- ---------
  Postop1CRP mg/dl          25 (±15)        43 (±25)       p=0.005
  Postop1PLT ×10^3^/mm^3^   206 (±42)       211 (±46)      p=0.655
  Prio (mean; SD)           10411 (±5262)   6118 (±3681)   p=0.003

RHH -- right hemihepatectomy; LLS -- left lateral sectionectomy; Postop1 -- 1^th^ postoperative day; CRP -- C-reactive protein; PLT -- platelet count; Prio -- postoperative regeneration-inflammatory ratio (Prio=PLT1/CRP1); SD -- standart deviation.
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